Author： Mo Yin-Yuan Moschos Stergios J
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.6, 2005-12, pp. : 1203-1216
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeting survivin in cancer therapy
By Pennati Marzia Folini Marco Zaffaroni Nadia
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. :
Access to resources
Recommend
Drugs targeting integrins for cancer therapy
By Binder Mascha Trepel Martin
Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. :
Targeting AAC-11 in cancer therapy
Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. :
Targeting ribonucleotide reductase for cancer therapy
By Shao Jimin Liu Xiyong Zhu Lijun Yen Yun
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. :
Targeting Mcl-1 for the therapy of cancer
By Quinn Bridget A Dash Rupesh Azab Belal Sarkar Siddik Das Swadesh K Kumar Sachin Oyesanya Regina A Dasgupta Santanu Dent Paul Grant Steven Rahmani Mohamed Curiel David T Dmitriev Igor Hedvat Michael Wei Jun Wu Bainan Stebbins John L Reed John C Pellecchia Maurizio Sarkar Devanand Fisher Paul B
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. :